AI Summary
StalkJBIO remains in a Stage 3 distribution phase, with structural repair underway after a failed continuation below the 9- and 20-day EMAs and the 50-day SMA. Medium-term bias is bearish, and near-term price is rejecting at resistance around the short-term EMAs, favoring sell-side execution now. Only a decisive reclaim above the 9- and 20-day EMAs and acceptance above the mid-August swing high would invalidate the bearish bias.
| METRIC | TREND |
|---|---|
| Sales, Adj. | — |
| YoY % | |
| P / Sales | |
| EV / Sales | |
| Gross Profit, Adj. | — |
| YoY % | |
| Margin % | |
| EV / Gross Profit | |
| EBITDA, Adj. | — |
| YoY % | |
| Margin % | |
| EV / EBITDA | |
| EBIT | — |
| YoY % | |
| Margin % | |
| EV / EBIT | |
| Net Income | — |
| YoY % | |
| Net Margin | |
| EPS (GAAP) | — |
| YoY % |